Most kidney transplant recipients settle at an eGFR between 50 and 60 mL/min/1.73 m², which is lower than the 90+ considered normal for healthy kidneys. That number might seem alarming, but a single functioning transplanted kidney performs differently than two native kidneys, and an eGFR in this range is associated with good long-term graft survival. What matters most isn’t hitting a specific number but understanding your personal baseline and watching for significant drops over time.
Typical eGFR at One Year Post-Transplant
The one-year mark is widely used as a benchmark for transplant kidney function. In a large study of U.S. transplant recipients from 2001 to 2013, the average one-year eGFR was about 55.5 mL/min/1.73 m² for both deceased and living donor kidneys. That average stayed remarkably stable over more than a decade despite changes in medications and surgical techniques, suggesting it represents a realistic ceiling for most transplants.
An eGFR below 60 technically places you in stage 3 chronic kidney disease, and many transplant recipients fall into this category at their one-year anniversary. Your transplant team will often add a “T” to the staging (stage 3T) to distinguish your situation from someone with native kidney disease. Being in stage 3T doesn’t mean your transplant is failing. It reflects the reality that one kidney, which may have sustained some injury during the donation and transplant process, simply filters less than two healthy ones would.
How Donor Type Affects Your Numbers
The kidney you received plays a big role in where your eGFR lands. Living donor kidneys generally produce higher eGFR values at one year compared to deceased donor kidneys, and they tend to last longer overall. Among deceased donors, the donor’s age matters significantly. Recipients who received a kidney from a donor older than 65 had a median one-year eGFR of just 39 mL/min/1.73 m², compared to 54 mL/min/1.73 m² for recipients of younger donor kidneys. About one in four recipients of older donor kidneys never reached an eGFR high enough to provide the survival benefit typically expected from transplantation.
If your eGFR is on the lower end, it’s worth understanding whether that reflects the donor kidney’s age and characteristics rather than a problem with how your body is handling the transplant. Your team can put your numbers in context based on the specific kidney you received.
How Fast eGFR Declines Over Time
After your eGFR stabilizes in the first year, expect a slow, gradual decline. Published estimates put the average loss at about 1 to 2 mL/min/1.73 m² per year. A pediatric transplant study found the annual rate of eGFR decline after transplant was around 5%, which was dramatically slower than the 18% annual decline these patients experienced before transplantation. That slow downward slope is normal and expected.
The pace of decline matters more than any single reading. Small fluctuations between visits, even a few points in either direction, are common and usually reflect hydration status, recent meals, or normal biological variation rather than a real change in kidney health. Your transplant team looks at the trend across multiple blood draws, not one isolated result.
When a Drop in eGFR Is Concerning
The threshold that should get your attention is a 30% or greater decline from your baseline eGFR. In a major study tracking transplant outcomes, a drop of this size (which occurred in about 10% of patients) was linked to a fivefold increase in graft failure and a twofold increase in the risk of death compared to patients with stable readings. That 30% decline turned out to be a stronger predictor of trouble than even a biopsy-confirmed episode of acute rejection.
For practical purposes: if your stable baseline is 55 and your eGFR drops to 38 or below, that’s a 30% decline and a signal that something needs investigation. Possible causes range from rejection to medication toxicity to dehydration or infection, many of which are treatable if caught early. Smaller dips, especially ones that bounce back at the next lab check, are less worrying.
How Immunosuppressants Affect Your eGFR
The very medications keeping your body from rejecting the kidney can also lower its function. Calcineurin inhibitors (the class that includes tacrolimus and cyclosporine) work by suppressing immune activity, but they also constrict blood vessels in the kidney, reducing blood flow and filtering capacity. This creates two distinct problems: a short-term, reversible dip in eGFR when drug levels run too high, and a slow, chronic form of kidney damage that develops over years of exposure.
When drug levels spike above the target range, you may see a sudden rise in creatinine and a corresponding drop in eGFR. This usually reverses once the dose is adjusted. The chronic effect is subtler, showing up as a gradual eGFR decline that can be difficult to separate from normal aging of the graft. Clinical trials have found that lower-dose tacrolimus regimens produce better eGFR at 12 months compared to higher doses or cyclosporine-based regimens. Reducing calcineurin inhibitor exposure generally improves eGFR because it eases the drug’s constrictive effect on kidney blood flow, but this has to be balanced against the risk of rejection.
Hydration and Daily Habits That Influence Readings
Staying well hydrated is standard advice after a kidney transplant, but the optimal range appears to be moderate rather than extreme. Research on living donor kidney recipients found that drinking 1,000 to 2,000 mL (roughly 4 to 8 cups) of water per day was associated with the best eGFR stability over time. Drinking less than a liter daily or pushing past two liters didn’t show the same benefit, and in some groups, very high fluid intake was actually linked to faster eGFR decline.
Dehydration before a blood draw can temporarily concentrate your creatinine and make your eGFR look worse than it really is. If you get a surprisingly low result, consider whether you were dehydrated, ill, or had recently eaten a large protein-rich meal, all of which can skew the number. A repeat test under normal conditions often tells a different story.
How Accurate Is Your eGFR Reading?
Standard eGFR calculations use creatinine, a waste product from muscle metabolism. In transplant recipients, creatinine-based formulas tend to overestimate true kidney function by about 3%, which is a small and generally acceptable margin. You may have heard that cystatin C, an alternative blood marker, offers better accuracy. In transplant patients, the opposite is true: cystatin C-based formulas underestimate actual kidney function by nearly 14% and perform worse overall. The most reliable approach for transplant recipients is the standard creatinine-based equation or a combined creatinine-cystatin C formula.
Keep in mind that eGFR is an estimate, not a direct measurement. Factors like muscle mass, age, and body composition all influence creatinine levels and can make the estimate less precise. If your team needs a highly accurate number for a specific clinical decision, they may order a direct GFR measurement using a tracer substance rather than relying on the standard blood test.